Description

ELTROMBOPAG

ELTROMBOPAG belongs to the class of ‘platelet-stimulating agents’ primarily used to treat low blood platelet count in patients with idiopathic thrombocytopenic purpura (ITP) and hepatitis C virus (HCV) infections. ELTROMBOPAG is also used to treat severe aplastic anaemia (SAA) in adults. Idiopathic thrombocytopenic purpura is an immune condition associated with low levels of platelets. Hepatitis C is an infection and inflammation of the liver caused due to hepatitis C virus. Severe aplastic anaemia is a condition in which the bone marrow doesn’t make enough blood cells.

ELTROMBOPAG contains ‘Eltrombopag’ which belongs to the class of ‘thrombopoietin receptor agonists’. Thrombopoietin is a glycoprotein hormone that stimulates the formation of megakaryocytes (large bone marrow cells) and further regulates platelet’s production. ELTROMBOPAG works by increasing these large bone marrow cells responsible for the production of platelets. Thus, ELTROMBOPAG helps increase these bone marrow cells, thereby stimulating the number of platelets, which further lowers the risk of bleeding.

Take ELTROMBOPAG as prescribed by your doctor. In some cases, ELTROMBOPAG can cause common side effects like nausea, diarrhoea, headache, muscle pain, tiredness, loss of appetite, fever, anaemia (lack of blood cells), cough and tingling numbness. These side effects are not familiar to everyone who take ELTROMBOPAG and vary individually. If you notice any side effects that are not manageable, please consult your doctor.

Let your doctor know if you have any allergic reactions to ELTROMBOPAG or any other medicines, before starting ELTROMBOPAG. It is essential to inform your doctor if you have any heart, kidney or liver problems, blood disorders, blood clotting problems and cataracts before starting ELTROMBOPAG. It is advised to consult the doctor if you are pregnant or planning to conceive. ELTROMBOPAG is not indicated for use in breastfeeding since it passes into the breast milk. ELTROMBOPAG may make you dizzy, hence drive or operate machinery only when you are mentally alert. 

Uses of ELTROMBOPAG

Low platelet count and Severe aplastic anaemia (SAA).

Medicinal Benefits

ELTROMBOPAG contains ‘Eltrombopag,’ which belongs to the class of ‘thrombopoietin receptor agonists’ used to treat low blood platelet count in patients with immune (idiopathic) thrombocytopenic purpura (ITP), hepatitis C virus (HCV) infections and severe aplastic anaemia (SAA) in adults. ELTROMBOPAG works by increasing megakaryocytes, the large bone marrow cells responsible for the production of platelets. The increase in these bone marrow cells stimulates the production of platelets. Thus ELTROMBOPAG prevents bleeding episodes by increasing the number of platelets in the blood.

Directions for Use

Tablet: Swallow it as a whole with a glass of water. Take it on an empty stomach as prescribed by the doctor. Do not crush, chew or break it. Oral suspension: Shake the bottle well before use. Take the prescribed dose by mouth using the measuring cup/dosing syringe/dropper provided by the pack. Powder: Mix the powder with the prescribed amount of water. Take it with or without food with an oral syringe in the dose and duration prescribed by the doctor.

Storage

Store in a cool and dry place away from sunlight.

Side Effects of ELTROMBOPAG

• Nausea
• Diarrhoea
• Headache
• Muscle pain
• Tiredness
• Loss of appetite
• Fever
• Anaemia (lack of blood cells)
• Cough
• Tingling or numbness